Asensus Surgical Announces Fukuoka Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
April 25 2023 - 6:55AM
Asensus Surgical, Inc., (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient to pioneer a new era of Performance-Guided
Surgery™(PGS), today announced that Fukuoka Tokushukai Hospital in
Kasuga City, Japan has entered into an agreement to lease and
utilize a Senhance® Surgical System.
“Japan remains one of our fastest-growing regions, and we are
delighted to bring another outstanding institution on board.
Fukuoka Tokushukai Hospital, which is part of Japan’s second
largest hospital system, is highly focused on delivering
cutting-edge care, and we are excited to partner with them to help
enable better outcomes for their patients,” said Anthony Fernando,
Asensus Surgical President and CEO. “Surgeons have continued to
recognize the benefits of Digital Laparoscopy coupled with
Senhance's clinical intelligence and digital tools as well as its
broad applicability. We look forward to accelerating the adoption
of Digital Laparoscopy throughout Japan and other key geographies
around the world.”
“Senhance is the only commercially available robotic surgery
system with haptic feedback, which provides doctors the ability to
feel the tissue response of the body during a procedure,” said Dr.
Noritomi Tomoaki, M.D., Ph.D., a gastrointestinal surgeon with a
specialty in hepatobiliary and pancreatic surgery and is also the
CEO of Fukuoka Tokushukai Hospital. “We are committed to giving our
patients the best care possible, and the Senhance System will
enable us to grow our robotic surgery department and improve
patient outcomes.”
The Senhance Surgical System is the only commercially available
robotic surgery system with haptic feedback, a differentiating
feature for surgeons.
About Fukuoka Tokushukai
Hospital
Fukuoka Tokushukai Hospital is located in Fukuoka Prefecture on
Kyushu, the southwestern- most of Japan’s main islands. Fukuoka
Tokushukai Hospital has 602 beds. The Hospital opened in 1979 and
is a part of the Tokushukai Medical Group, the second largest
private hospital system in Japan operating 400 facilities,
including clinics and nursing care facilities and approximately 75
hospitals. The Tokushukai Medical Group accounts for nearly 3% of
all emergency medical care in Japan and has adopted a North
American style ER (Emergency Room) system. Tokushukai Medical Group
philosophy is “All living beings are created equal”.Under this
philosophy, aiming to realize the society where at any time, in
anywhere and to anybody are to receive cutting-edge medical care,
Tokushukai Medical Group practices emergency medical care,
preventive medical care, chronic and advanced medical care.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery™ by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery. Based
upon the foundations of Digital Laparoscopy and the Senhance®
Surgical System, the Company is developing the LUNA™ Surgical
System, a next generation robotic and instrument system as a
foundation of its Digital Surgery solution. These systems will be
powered by the Intelligent Surgical Unit to increase surgeon
control and reduce surgical variability. With the addition of
machine vision, Augmented Intelligence, and deep learning
capabilities throughout the surgical experience, we intend to
holistically address the current clinical, cognitive and economic
shortcomings that drive surgical outcomes and value-based
healthcare. The Senhance Surgical System is now available for sale
in the US, EU, Japan, Russia, and select other countries. For a
complete list of indications for use, visit:
www.senhance.com/indications. To learn more about
Performance-Guided Surgery, Digital Laparoscopy with the Senhance
Surgical System and the new LUNA System visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn:
https://www.linkedin.com/company/asensus-surgical-inc
Twitter: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/c/transenterix
Vimeo: https://vimeo.com/asxc
TikTok: https://www.tiktok.com/@asensus_surgical
Forward-Looking Statements
This press release includes statements relating to the Senhance
Surgical System and Fukuoka Tokushukai Hospital in Kasuga City,
Japan initiating a program with the Senhance System. These
statements and other statements regarding our future plans and
goals constitute "forward looking statements" within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and are intended to qualify for
the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. Such statements are
subject to risks and uncertainties that are often difficult to
predict, are beyond our control and which may cause results to
differ materially from expectations and include whether Asensus
Surgical can accelerate the adoption of the Senhance Surgical
System throughout Japan and other key geographies around the world
and whether the Senhance Surgical System will enable Fukuoka
Tokushukai Hospital to grow its robotic surgery department and
improve patient outcomes. For a discussion of the risks and
uncertainties associated with the Company’s business, please review
our filings with the Securities and Exchange Commission (SEC),
including our Annual Report on Form 10-K for the year ended
December 31, 2022, filed with the SEC on March 2, 2023 and our
other filings we make with the SEC. You are cautioned not to place
undue reliance on these forward looking statements, which are based
on our expectations as of the date of this press release and speak
only as of the origination date of this press release. We undertake
no obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise.
INVESTOR CONTACT:
Mark Klausner or Mike VallieICR
Westwickeinvest@asensus.com443-213-0499
MEDIA CONTACT:Dan VentrescaMatter
CommunicationsAsensusPR@matternow.com617-874-5488
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/f5bfac32-2f7f-4040-8ece-4a67adec3fab
Asensus Surgical (AMEX:ASXC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Asensus Surgical (AMEX:ASXC)
Historical Stock Chart
From Apr 2023 to Apr 2024